ADHD References
1.Biederman Joseph, Faraone Stephen, et al: A prospective 4 year Follow-up Study of Attention-Deficit Hyperactivity disorder and Related Disorders. Arch Gen Psychiatry 1996;53:437-446
2 Child and Adolescent Psychopharmacology Course,
3. Barrickman LL, Perry PJ, et al: Buproprion versus Methylphenidate in the Treatment of Attention Deficit Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry 1995, 34,5:649-657.
4. Conners KC, Casat CD, et al: Bupropion Hydrochloride in Attention Deficit Disorder with Hyperactivity. J Am Acad Child Adolesc Psychiatry 1996,35;1314-1321.
5. Cantwell DP: ADHD Through the Life Span: the role of Bupropion in treatment. J Clin Psychiatry 1998;59[suppl 4]:92-94.
6. Gerring JP, Brady KD, et. al: Premorbid Prevalence of ADHD and Development of Secondary ADHD after closed head injury. 1998 J Am Acad Child Adolesc Psychiatry 37(6):647-654.
7. Firestone P, Monteiro M, et. al: Short-term Side Effects of Stimulant Medication Are Increased in Preschool Children with ADHD; A Double-Blind Placebo-Controlled Study. Journal of Child and Adolescent Psychopharmacology 1998 8(1) 13-25.
8.Pliszka SR: Comorbidity of Attention Deficit Hyperactivity disorder with Psyhciatric Disorder: an Overview. J Clin Psychiatry 1998;59[suppl 7]:50-58.
9. Dunner DL, Zisook S, et al: A Prospective Safety Surveillance Study for Buproprion Sustained-Release in the Treatment of Depression. J Clin Psychiatry 1998;59:366-373.
10. Gozal D: Sleep-disordered breathing and school performance in children. Pediatrics 1998 Sep; 102(3 Pt 1): 616-20.
11. Gross-Tsur V Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective? - J Pediatr - 1997 Apr; 130(4): 670-4.
12. Brasseux C, D'Angelo LJ, et al: The Changing Patttern of Substance Abuse in Urban Adolescents. Arch Pediatr Adolesc Med 1998;152:234-237.
13.Lavigne JV, Arend R, et al: Psychiatric disorders With Onset in the Preschool Years: I. Stability of Diagnosis. 1998 J Am Acad Child Adolesc Psychiatry 37(12):1246-1254
14.. Lavigne JV, Arend R, et al: Psychiatric disorders With Onset in the Preschool Years:II Correlates and Predictors of Stable Case Status1998 J Am Acad Child Adolesc Psychiatry 37(12):1255-1261.
15. Riggs PD, Leon SL, et al: An Open Trial of Buproprion ADHD in Adolescents With Substance Use Disorders and Conduct Disorder. 1998 J Am Acad Child Adolesc Psychiatry 37(12):1271-1278.
16. Strassberger E ,Donnerstein D: Children,
Adolescents, and the Media: Issues and Solutions (1999) Pediatrics 103:1:126-139.
17. Stevens LJ :Omega-3 fatty acids in boys with behavior, learning, and health problems. Physiol Behav (1996)Apr-May; 59(4-5): 915-20.
18. Murphy JM, Pagano ME, et al: the relationship of school breakfast to psychosocial and academic functioning. Arch Pediatr Adolesc Med 152:89, 1998.
19. Kuperman S, Schlosser SS, et al: Relationship of Child Psychopathology to Parental Alcoholism and Antisocial Personality Disorder. J Am Acad Child Adolesc Psychiatry 1999, 38(6):686-692.
20. Handen BL, Feldman HM et al: Efficacy of Methylphenidate Among Preschool Children With Developmental Disabilites and ADHD. . J Am Acad Child Adolesc Psychiatry 1999, 38(7):805-812.
21. Gutgesell H, Atkins D, et al: AHA Scientific Statement: cardiovascular Monitoring of Children and Adolescents Receiving Psychotropic Drugs. J Am Acad Child Adolesc Psychiatry 1999, 38(8):1047-1050.
22. Disney ER, Elkins IJ, et al: Effects of ADHD, Conduct Disorder, and Gender on Substance use and Abuse in Adolescence. Am J Psychiatry 1999, 156:1515-1521.
23. Biederman J, Wilens T, et al: Psychoactive substance use disorders in adults with attention-deficit hyperactivity disorder (ADHD) Am J Psychiatry 1995,152: 1652-1658.
24. Biederman J, et al: Pharmacotherapy of Attention-Deficit Hyperactivity Disorder Reduces Risk for Substance Use Disorder Pediatrics 1999;104 August (from internet section of the journal)
25. Cook EH: The Early Development of Child Psychophamacogenetics. . J Am Acad Child Adolesc Psychiatry 1999, 38(12) 1478-1481.
26. MTA cooperative group The Multimodal Treatment Study of Children With ADHD Arch Gen Psychiatry. 1999;56:1073-1086
27. MTA cooperative group: Moderators and Mediators of Treatment Response for Children with ADHD Arch Gen Psychiatry 1999, 56:1088-1096
28.Mota VL, Schachar RJ:
Reformulating Attention-Deficit/Hyperactivity Disorder According to Signal
Detection Theory. J Am Acad Child Adolesc Psychiatry2000, 39(9):1144-1151.\
29. Greenhill LL, Swanson JM et. al: Impairment and Deportment Respinses to Different Methylphenidate Doses in Children with ADHD: the MTA Titration Trial. J Am Acad Child Adolesc Psychiatry2001, 40(2):180-187
30. Vitiello B, Severe JB, et al: Methylphenidate Dosage for Children with ADHD Over Time Under Controlled conditions: Lessons from the MTA. J Am Acad Child Adolesc Psychiatry2001, 40(2):188-196.
31. DuPaul GJ, McGoey KE, et. al. : Preschool Children With ADHD: Impairments in Behavioral, Social and School Functioning. . J Am Acad Child Adolesc Psychiatry2001, 40(5): 508-515
32.Ghuman JK, Ginsburg GS, et. al.: Psychostimulants in Preschool Chidlren with ADHD: Clinical Evidence from a Developmetal Disorders Institution. . J Am Acad Child Adolesc Psychiatry2001, 40(5):516-524.
. 33. Voigt RG, Llorente AM, et. al: A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder J Pediatr 2001;139:189-96.
34. Brown TE: DSM-IV: ADHD and Executive Function Impairments. Advanced Studies in Medicine 2002;2 (25): 910-914.
36. Swanson J, Gupta S et al: Development of a New Once-a-Day Formulation of Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder. Arch Gen Psychiatry, 2003;60:204-211.
37. McCracken JT, Biederman J, et al: Analog Classroom Assessment of a Once-Daily Mixed Amphetamine Formulation, SL1381 (ADDERALL XR) in Children With ADHD. J Am Acad Child Adolesc Psychiatry 2003 Jun;42(6); 673-688.
38 McGough JJ, Biederman J et al: Pharmacokinetics of SL1381 (ADDERALL XR), and Extended -Release Formulation of Adderall. J Am Acad Child Adolesc Psychiatry 2003 Jun;42(6); 673-688
41. Lee TS: Atomoxetine and
tics in ADHD. J Am Acad Child Adolesc
Psychiatry -
42. Kratochvil CJ: Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.
J Am Acad Child Adolesc Psychiatry -
43. Michelson D: Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study.
- J Am Acad Child Adolesc Psychiatry -
44. MD Consult Website: FDA announces new warning for ADHD
medication. In “This
Week In Medicine”,
45. Haag M: Essential fatty acids and the brain.Can J Psychiatry - 01-APR-2003; 48(3): 195-203
46. Hirayama S: Effect of docosahexaenoic
acid-containing food administration on symptoms of
attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study.Eur J Clin Nutr -
47. Voigt RG :A randomized,
double-blind, placebo-controlled trial of docosahexaenoic
acid supplementation in children with attention-deficit/hyperactivity disorder.
J Pediatr -
48. The Oxford-Durham Study: A Randomized, Controlled Trial
of Dietary Supplementation With Fatty Acids in Children With Developmental
Coordination Disorder PEDIATRICS Vol. 115 No.
49. Richardso AJ, Puri BK A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Feb;26(2):233-9.
50.Ulrike Steuerwald Pal Weihe: Maternal seafood diet, methylmercury exposure, and neonatal neurologic function J Pediatr 2000;136:599-605
51. Schab DW, Trinh N: Do Artificial Colors Promote Hyperactivity in Children with Hyperactive Syndromes? Ameta-Analysis of Double-Blind Placebo-Controlled Trials. J Dev Behav Pediatr 25: 423-434, 2004
|
|
52.Baldwin RL, Chelonis
JJ,et al: Effect of methylphenidate on time
perception in children with attention-deficit/hyperactivity disorder. Exp Clin Psychopharmacol. 2004 Feb;12(1):57-64.
|
53. Radonovich KJ, Mostofsky SH: Duration judgments in children with ADHD suggest deficient utilization of temporal information rather than general impairment in timing. Neuropsychol Dev Cogn C Child Neuropsychol. 2004 Sep;10(3):162-72. 54. Rasmussen P, Gillberg C Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study.J Am Acad Child Adolesc Psychiatry. 2000 Nov;39(11):1424-31 55. Smits MG: Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial. J Am Acad Child Adolesc Psychiatry -
56. Weiss M, Tannock
R et al:A randomized,
placebo-controlled study of once-daily atomoxetine
in the school setting in children with ADHD. 57. Newcorn JH, Spencer TJ et. Al: Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2005 Mar;44(3):240-8. 58. Cortese S, Konofal E, et al: RLS and ADHD: a Review of the Literature. Sleep 2005;28(8):1007-1013. 59. Guilleminault C :Sleepwalking and sleep terrors in prepubertal
children: what triggers them? Pediatrics - 60. Konofal E: Ropinirole in a child with attention-deficit hyperactivity disorder
and restless legs syndrome. Pediatr
Neurol - 61. Rosen C: Obstructive sleep apnea syndrome in children:
controversies in diagnosis and treatment.Pediatr Clin North Am - 62. Meltzer LJ, Mindell JA Nonpharmacologic treatments for pediatric sleeplessness. Pediatr Clin North Am. 2004 Feb;51(1):135-51. 63. Owens JA: The ADHD and sleep conundrum: a review.J Dev Behav Pediatr - 64. Donnelly G: Double-blind, Placebo-Controlled,
Crossover Study of Multiplayer-Release Methylphenidate in Adult ADHD.
Abstract C-19 American and
|
.
|
|